You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com
HCV - Hepatocellular Carcinoma
Peretinoin Improves Hepatocellular Carcinoma in People with Mild Liver Impairment 1-28-2011 Do IL28B Gene Variations Affect Liver Disease Progression in People with Hepatitis C? 11-19-2010 Racial/ethnic and Socioeconomic Disparities in Survival of People with Liver Cancer 2-12-2010 Transcatheter Arterial Chemoembolization Does Not Improve Survival in Liver Cancer Patients Undergoing Chemotherapy 1-29-2010 Liver Cancer Drug Sorafenib (Nexavar) Inhibits Hepatitis C Virus Replication in Laboratory Study 1-08-2010 Researchers Identify Markers for Aggressive Liver Cancer 10-30-2009 Diets High in Protein and Cholesterol May Increase Risk of Liver Cirrhosis and Cancer, while Carbohydrates May Be Protective 8-7-2009 Metabolic Syndrome Is Associated with Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients 6/09/09 A Small Proportion of Hepatitis C Patients Develop Liver Cancer despite Sustained Response to Interferon-based Therapy 4/13/09 Long-term Maintenance Interferon Did Not Prevent Hepatocellular Carcinoma among Chronic Hepatitis C Patients in HALT-C Study 3/17/2009 U.S. Liver Cancer Rate Triples, but Survival Improves 3/13/2009 Open Phase 3 Study of Eltrombopag for Raising Platelet Levels in Patients with Chronic Liver Disease and Thrombocytopenia 2/27/09 Hepatitis C Virus May Persists at Low Levels after Sustained Response to Treatment; Liver Cancer May Develop Years Later 2/06/2009 Sustained Virological Response to Pegylated Interferon plus Ribavirin for Chronic Hepatitis C Does Not Always Prevent Hepatocellular Carcinoma 10/10/08 STORM Trial to Assess Sorafenib (Nexavar) as Adjuvant Therapy for Patients with Liver Cancer 9/12/2008 Hepatocellular Carcinoma Rates Vary Widely Across Sex and Racial/Ethnic Groups 7/25/08 Two Studies Look at Promising Therapies for Liver Cancer 7/25/08
Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C 7/04/08 Incidence of and Risk Factors for Hepatocellular Carcinoma in Hepatitis C Patients with Advanced Liver Disease: HALT-C Trial 5/16/08
Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis Anemia Children / Infants / Women Drug Abuse Experimental Treatments FAQs About Hepatitis C Genotypes Insulin Resistance / Diabetes Sustained Viral Response (SVR) Tests for HCV Vaccines for HCV
